| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biogen Inc. (BIIB) has 15 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. BIIB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 31.0K | $6.04M | - | |
| Dir | 24.3K | $4.74M | - | |
| Dir | 13.7K | $2.67M | - | |
| Dir | 9.8K | $1.90M | - | |
| Dir | 8.9K | $1.73M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | Singhal Priya74 | Head Of Development | Sale+OE | 517 | $133.55 | $69,045.35 | -8.2% | +27.3% | - | |
| Jul 8, 2025 | Izzar Rachid | Head Of Global Product Strat. | Sell | 2,223 | $135.00 | $300,105.00 | -26.0% | +14.6% | - | |
| May 19, 2025 | Singhal Priya74 | Head Of Development | Sell | 3,806 | $126.25 | $480,507.50 | -41.2% | +5.0% | - | |
| May 2, 2025 | Dorsa Caroline57 | Director | Buy | 1,235 | $122.72 | $151,559.20 | +4.6% | +3.6% | +51.4% | |
| Mar 7, 2025 | Sherwin Stephen A | Director | Sell | 8,760 | $150.02 | $1,314,141.91 | -43.6% | -13.3% | +22.9% | |
| Dec 9, 2024 | Singhal Priya74 | Head Of Development | Sale+OE | 110 | $157.21 | $17,293.10 | -2.0% | -3.7% | +12.4% | |
| Sep 3, 2024 | Singhal Priya74 | Head Of Development | Sale+OE | 431 | $204.22 | $88,018.82 | -7.5% | -19.8% | -30.9% | |
| Apr 2, 2024 | Singhal Priya74 | Head Of Development | Sell | 93 | $213.09 | $19,817.37 | -1.9% | +11.6% | -36.8% | |
| Feb 22, 2024 | Singhal Priya74 | Head Of Development | Sell | 262 | $221.23 | $57,962.26 | -5.1% | +1.2% | -36.8% | |
| Feb 16, 2024 | Singhal Priya74 | Head Of Development | Sale+OE | 108 | $221.49 | $23,920.92 | -2.1% | +5.0% | -37.3% |